MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$559,000
Net Income
-$28,614,000
Net Profit Margin
-5118.78%
EPS
-$0.21
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Total revenues
559,000
238,000
-
0
Cost of product sales
32,000
14,000
-
-
Research and development, net of tax credits
3,509,000
3,251,000
3,940,000
3,669,000
General and administrative
-
4,824,000
3,263,000
3,759,000
Commercial
-
15,812,000
4,626,000
5,103,000
Selling, general and administrative
22,648,000
-
-
-
Total operating expenses
26,189,000
23,901,000
-
-
Loss from operations
-25,630,000
-23,663,000
-11,829,000
-12,531,000
Interest income
1,741,000
1,732,000
874,000
516,000
Interest expense
4,725,000
4,135,000
967,000
951,000
Net loss and comprehensive loss
-28,614,000
-26,066,000
-11,922,000
-12,966,000
Basic EPS
-0.21
-0.2
-0.12
-0.2
Diluted EPS
-0.21
-0.2
-0.12
-0.2
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss and
comprehensive loss
-$28,614,000
(-120.68%↓ Y/Y)
Interest income
$1,741,000
(237.40%↑ Y/Y)
Loss from operations
-$25,630,000
(-104.53%↓ Y/Y)
Interest expense
$4,725,000
(396.85%↑ Y/Y)
Total revenues
$559,000
Total operating
expenses
$26,189,000
Selling, general and
administrative
$22,648,000
Research and
development, net of tax...
$3,509,000
(-4.36%↓ Y/Y)
Cost of product sales
$32,000
Buy us a coffee
Milestone Pharmaceuticals Inc. (MIST)
Milestone Pharmaceuticals Inc. (MIST)